Seeking Alpha
Bonds, dividend investing, ETF investing
Profile| Send Message|
( followers)  

The table below lists the top 20 global drug companies based on sales in 2009:

S.No. Company Ticker 2009 Revenues in US $ (Milllions)
1 Pfizer PFE $45,448
2 Sanofi-Aventis SNY $40,871
3 Novartis NVS $38,455
4 GlaxoSmithKline GSK $36,746
5 AstraZeneca AZN $31,905
6 Merck & Co. MRK $26,929
7 Johnson & Johnson JNJ $22,520
8 Eli Lilly & Co. LLY $20,629
9 Bristol-Myers Squibb BMY $18,808
10 Abbott Laboratories ABT $16,486
11 Takeda Chem Ind. OTC:TKPHY $14,204
12 Boehringer-Ingelheim $14,027
13 Teva Pharma TEVA $13,814
14 Bayer Schering OTCPK:BAYRY $13,344
15 Astellas OTCPK:ALPMY $10,509
16 Daiichi-Sankyo OTC:DSKYY $9,757
17 Eisai OTCPK:ESALY $8,441
18 Otsuka $7,717
19 Gilead Sciences GILD $6,469
20 Mylan MYL $5,015

Source: Contract Pharma

Otsuka, Gilead and Mylan are new to this list. Half of the companies ranked 11-20 are based in Japan. Though currently ranked at number 13, Israel-based Teva (NYSE:TEVA), the world’s largest generic drug maker, has revenue goals that could propel it into the top 7 ranks in the next few years. U.S.-based Gilead (NASDAQ:GILD) primarily focuses on developing drugs for life-threatening diseases diseases such as HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.

Disclosure: No positions

Source: The Top 20 Global Pharmaceuticals by Sales